DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Amatuximab is an investigational drug.
There have been 4 clinical trials for Amatuximab. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2015.
The most common disease conditions in clinical trials are Mesothelioma, Carcinoma, Non-Small-Cell Lung, and Ovarian Neoplasms. The leading clinical trial sponsors are Morphotek, National Cancer Institute (NCI), and [disabled in preview].
Recent Clinical Trials for Amatuximab
|Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM).||Morphotek||Phase 2|
|A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers||Morphotek||Phase 1|
|Amatuximab for High Mesothelin Cancers||National Cancer Institute (NCI)||Phase 0|